SCHEMBL21057641

SCHEMBL21057641

FC1(F)CCC(Cn2ncc3cc(I)ccc32)CC1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
BRD4 O60885 5/20 0.38
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
CHRM2 P08172 2/20 0.34
CHRM1 P11229 2/20 0.34
SLC6A4 P31645 1/20 0.34
CRHR1 P34998 1/20 0.34
KMO O15229 1/20 0.33
PLK1 P53350 1/20 0.31
IRAK1 P51617 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21057855 0.88 HDAC1 (0.48) HDAC1HDAC2BRD4HTR2AHTR2C
SCHEMBL21057930 0.77 TEAD1 (0.36) HTR2A
SCHEMBL13432163 0.71 CHRM2 (0.54) HDAC1HDAC2BRD4HTR2AHTR2C
SCHEMBL2445835 0.71 HDAC1 (0.46) HDAC1HDAC2BRD4HTR2AHTR2C
SCHEMBL27083872 0.71 HDAC1 (0.51) HDAC1HDAC2BRD4HTR2AHTR2C
SCHEMBL20476763 0.69 KDM5A (0.52) HDAC1HDAC2
SCHEMBL21057768 0.69 HTR2A (0.52) HDAC1HDAC2HTR2AHTR2CCHRM2
SCHEMBL20325546 0.69 HDAC1 (0.47) HDAC1HDAC2BRD4CNR1CNR2
SCHEMBL12328689 0.69 GRM2 (0.42) HDAC1HDAC2BRD4HTR2AHTR2C
SCHEMBL15687430 0.69 HDAC1 (0.47) HDAC1HDAC2BRD4CNR2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12344605-B2 Substituted pyrrolidine amides II GRUENENTHAL GMBH (DE) 2025-07-01 US disclosed
US-20220127264-A1 SUBSTITUTED PYRROLIDINE AMIDES II GRUENENTHAL GMBH (DE) 2022-04-28 US disclosed
US-20220127264-A1 SUBSTITUTED PYRROLIDINE AMIDES II GRUENENTHAL GMBH (DE) 2022-04-28 US disclosed
EP-3728233-B1 SUBSTITUTED PYRROLIDINE AMIDES II GRUENENTHAL GMBH (DE) 2022-04-20 EP disclosed
EP-3728233-B1 SUBSTITUTED PYRROLIDINE AMIDES II GRUENENTHAL GMBH (DE) 2022-04-20 EP disclosed
EP-3728233-A1 SUBSTITUTED PYRROLIDINE AMIDES II Grünenthal GmbH (DE) 2020-10-28 EP disclosed
CN-111491931-A Substituted pyrrolidine amides II 格吕伦塔尔有限公司 2020-08-04 CN disclosed
US-20190185470-A1 Substituted Pyrrolidine Amides II GRUENENTHAL GMBH (DE) 2019-06-20 US disclosed
US-20190185470-A1 Substituted Pyrrolidine Amides II GRUENENTHAL GMBH (DE) 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185470-A1 Substituted Pyrrolidine Amides II NR3C1, NR3C2, MC2R HDAC1 385/4885HDAC2 340/4885BRD4 1490/4885
US-20220127264-A1 SUBSTITUTED PYRROLIDINE AMIDES II NR3C1, NR3C2, MC2R HDAC1 385/4885HDAC2 340/4885BRD4 1490/4885
US-12344605-B2 Substituted pyrrolidine amides II NR3C1, NR3C2, MC2R HDAC1 385/4885HDAC2 340/4885BRD4 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.